Click to Share
 

Scm Pharma Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Visiongain
A new report by visiongain, a London-based business information company, predicts that world revenues for antibacterial drugs will reach $43.81bn in 2016.
By Visiongain
A new report by visiongain predicts that revenues for disease-modifying treatments for multiple sclerosis (MS) will rise to $15.8bn annually in 2015. That analysis appears in Multiple Sclerosis Treatment: World Drug Market 2012-2022.
By Visiongain
A new report by visiongain, a London-based business information provider, predicts that the global medical device contract manufacturing revenues will reach $95.7bn in 2021.
By Visiongain
Visiongain predicts that world revenues for rheumatoid arthritis drugs will rise strongly between 2011 and 2021. This market will grow to reach $17.3bn in 2015. The rheumatoid arthritis drugs market generated $12.7bn in 2010.
By Visiongain
A new report by visiongain predicts that the global companion diagnostics market will be worth $3.45bn by 2015. The market generated sales of $1.30bn in 2010, according to Companion Diagnostics: World Market Outlook 2011-2021, published in August.
By Visiongain
A new report by visiongain, a London-based business information company, predicts that global pharmacovigilance spending will be worth $15.46bn by 2015. The market was worth just under $12bn in 2010.
By Raman Sehgal
UK-BASED SCM Pharma is set to open its first US office after appointing a North American based business development manager to boost the company’s export revenue.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share